Brookings Roundtable on Active Medical Product Surveillance
Topic: Learnings from the Department of Veterans Affairs Active Surveillance Activities
Date: Monday, June 20, 2011
Time: 1:30 pm - 2:30 pm (EST)
Where: Webinar/Teleconference (Registration is required)
The roundtable will feature a presentation by Dr. Fran Cunningham, Associate Chief Consultant, Center for Medication Safety Program Manager, Outcomes Research, Department of Veterans Affairs (VA) and Dr. Chester B. (Bernie) Good, Associate Professor of Medicine and Pharmacy, Staff Physician, VA Pittsburgh Healthcare System, Co-Director, Center for Medication Safety. The VA has been conducting a number of activities related to active surveillance within their own databases, which contain clinically enriched data for war veterans, a population that may differ in important ways from the general population. Dr. Cunningham and Dr. Good will discuss methods used and lessons learned from two of the VA's active surveillance activities: Signal refinement studies conducted to evaluate safety concerns arising within the VA population; and assesing and operationalizing the common data model used by the Observational Medical Outcomes Partnership (OMOP).
Webinar log in and teleconference information can be found in your registration confirmation email.
To register and to view the agenda ► Brookings Roundtable on Active Medical Product Surveillance - Event Summary | Online Registration by Cvent.
Please feel free to forward this invitation to interested colleagues. To learn more about the Brookings Active Surveillance Roundtable webinar and teleconference series, visit our website at http://www.brookings.edu/health/Projects/surveillance/roundtables.aspx
Note: This roundtable will have an online webinar component to facilitate more interactive presentations and discussions. As in past roundtables, it is still possible to participate only by teleconference.
Active Medical Product Surveillance Roundtables - - Brookings Institution
miércoles, 8 de junio de 2011
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario